In summary, boosted VaxCCP neutralized more than 95% of SARS-CoV-2 Omicron BQ.1.1, BF.7, and XBB. Samples collected within a six-month window from boosted individuals without prior infection had half the nAb levels as VaxCCP specimens. Taken together, boosted VaxCCP could be a viable substitute for anti-SARS-CoV-2 mAbs for passive immunotherapy of IC patients. The researchers suggested revising guidelines to include boosted VaxCCP for COVID-19 treatment in IC patients.
1）打过booster+被传染过
2）打过booster+没被传染过 （nAb levels half of 1）)
...
https://www.news-medical.net/news/20221130/Plasma-from-vaccinated-and-COVID-19-convalescent-subjects-as-passive-immunotherapy-against-the-new-Omicron-BQ11-XBB-and-BF7-variants.aspx
。。。
ConclusionsIn summary, boosted VaxCCP neutralized more than 95% of SARS-CoV-2 Omicron BQ.1.1, BF.7, and XBB. Samples collected within a six-month window from boosted individuals without prior infection had half the nAb levels as VaxCCP specimens. Taken together, boosted VaxCCP could be a viable substitute for anti-SARS-CoV-2 mAbs for passive immunotherapy of IC patients. The researchers suggested revising guidelines to include boosted VaxCCP for COVID-19 treatment in IC patients.
打了之后容易得但是不重。从此却有了对Omicron的真抗体。当然，几个月后又没抗体了，再来一圈。